PHIO | Phio Pharmaceuticals
Next ER: May 18, 2023 Before Market Opens
About the Company
Phio Pharmaceuticals Inc. is a US biotechnology company focused on the field of siRNA. The company's name was changed to Phios Pharmaceuticals in 2018. The company is using its siRNA platform to develop a pipeline of dermatology and ophthalmology therapeutics.
NASDAQ - Nasdaq Stock Market
More profiles and info about the company
News for (PHIO)
This company doesn't provide a dividend.
Talk about Phio Pharmaceuticals below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
( FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relationssite.
Support this project
If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
Buy on Amazon
Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!